XML 35 R22.htm IDEA: XBRL DOCUMENT v3.25.4
Segment Reporting
12 Months Ended
Dec. 31, 2025
Segment Reporting  
Segment Reporting

15. Segment and Geographic Reporting

We report segment information based on the various industries in which our businesses operate and how we manage those businesses in accordance with our investment strategies, which may include: identifying and acquiring undervalued assets and businesses, often through the purchase of distressed securities; increasing value through management, financial or other operational changes; and managing complex legal, regulatory or financial issues, which may include bankruptcy or insolvency, environmental, zoning, permitting and licensing issues. Therefore, although many of our businesses are operated under separate local management, certain of our businesses are grouped together when they operate within a similar industry, comprising similarities in products, customers, production processes and regulatory environments, and when such businesses, when considered together, may be managed in accordance with one or more investment strategies specific to those businesses.

Our reportable segments reflect the way the Company is managed, and for which separate financial information is available and evaluated regularly by the Company’s Chief Operating Decision Maker (“CODM”) in deciding how to allocate resources and assess performance. The Chairman of the Board of Directors of our general partner, who is our CODM, reviews financial information for each segment and evaluates the results in relation to our broader business strategies. Accordingly, segment operating results are assessed based on net income from continuing operations attributable to Icahn Enterprises. Assets provided to the CODM are consistent with those reported in the condensed consolidated balance sheets, and there are no intra-entity sales or transfers, or significant expense categories regularly reviewed by the CODM beyond those disclosed in the condensed consolidated statements of operations.

Certain terms of financings for certain of our businesses impose restrictions on the business’ ability to transfer funds to us, including restrictions on dividends, distributions, loans and other transactions. Our condensed statements of operations and balance sheets by reporting segment are presented below.

Condensed Statements of Operations

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Year Ended December 31, 2025

​

  ​ ​ ​

Investment

  ​ ​ ​

Energy

  ​ ​ ​

Automotive

  ​ ​ ​

Food Packaging

  ​ ​ ​

Real Estate

  ​ ​ ​

Home Fashion

  ​ ​ ​

Pharma

  ​ ​ ​

Holding Company

  ​ ​ ​

Consolidated

​

​

(in millions)

Revenues:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Net sales

​

$

—

​

$

7,162

​

$

835

​

$

364

​

$

1

​

$

170

​

$

99

​

$

—

​

$

8,631

Other revenues from operations

 

​

—

 

​

—

 

​

601

 

​

—

 

​

58

 

​

—

 

​

5

 

​

—

 

​

664

Net loss from investment activities

 

​

(183)

 

​

—

 

​

—

 

​

—

 

​

—

 

​

—

 

​

—

 

​

—

 

​

(183)

Interest and dividend income

 

​

189

 

​

30

 

​

3

 

​

—

 

​

7

 

​

—

 

​

1

 

​

58

 

​

288

(Loss) gain on disposition of assets, net

 

​

—

 

​

(7)

 

​

(16)

 

​

—

 

​

270

 

​

—

 

​

—

 

​

—

 

​

247

Other income (loss), net

 

​

6

 

​

3

 

​

—

 

​

(2)

 

​

—

 

​

1

 

​

—

 

​

3

 

​

11

​

 

​

12

 

​

7,188

 

​

1,423

 

​

362

 

​

336

 

​

171

 

​

105

 

​

61

 

​

9,658

Expenses:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Cost of goods sold

 

​

—

 

​

6,860

 

​

591

 

​

327

 

​

1

 

​

139

 

​

60

 

​

—

 

​

7,978

Other expenses from operations

 

​

—

 

​

—

 

​

537

 

​

—

 

​

62

 

​

—

 

​

—

 

​

—

 

​

599

Selling, general and administrative

 

​

16

 

​

178

 

​

446

 

​

54

 

​

22

 

​

43

 

​

49

 

​

29

 

​

837

Dividend expense

​

​

35

 

​

—

 

​

—

 

​

—

 

​

—

 

​

—

 

​

—

 

​

—

 

​

35

Restructuring, net

 

​

—

 

​

—

 

​

—

 

​

9

 

​

—

 

​

1

 

​

—

 

​

—

 

​

10

Impairment

​

​

—

​

​

—

​

​

25

​

​

15

​

​

—

​

​

—

​

​

—

​

​

—

​

​

40

Interest expense

 

​

15

 

​

135

 

​

2

 

​

10

 

​

—

 

​

2

 

​

—

 

​

340

 

​

504

​

 

​

66

 

​

7,173

 

​

1,601

 

​

415

 

​

85

 

​

185

 

​

109

 

​

369

 

​

10,003

(Loss) income before income tax (expense) benefit

 

​

(54)

 

​

15

 

​

(178)

 

​

(53)

 

​

251

 

​

(14)

 

​

(4)

 

​

(308)

 

​

(345)

Income tax (expense) benefit

 

​

—

 

​

27

 

​

48

 

​

(13)

 

​

5

 

​

—

 

​

—

 

​

(48)

 

​

19

Net (loss) income

 

​

(54)

 

​

42

 

​

(130)

 

​

(66)

 

​

256

 

​

(14)

 

​

(4)

 

​

(356)

 

​

(326)

Less: net (loss) income attributable to non-controlling interests

 

​

(59)

 

​

38

 

​

—

 

​

(6)

 

​

—

 

​

—

 

​

—

 

​

—

 

​

(27)

Net (loss) income attributable to Icahn Enterprises

​

$

5

​

$

4

​

$

(130)

​

$

(60)

​

$

256

​

$

(14)

​

$

(4)

​

$

(356)

​

$

(299)

Supplemental information:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Capital expenditures

​

$

—

​

$

185

​

$

95

​

$

35

​

$

18

​

$

8

​

$

—

​

$

—

​

$

341

Depreciation and amortization

​

$

—

​

$

468

​

$

65

​

$

19

​

$

18

​

$

5

​

$

28

​

$

—

​

$

603

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Year Ended December 31, 2024

​

  ​ ​ ​

Investment

  ​ ​ ​

Energy

  ​ ​ ​

Automotive

  ​ ​ ​

Food Packaging

  ​ ​ ​

Real Estate

  ​ ​ ​

Home Fashion

  ​ ​ ​

Pharma

  ​ ​ ​

Holding Company

 

Consolidated

​

​

(in millions)

Revenues:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Net sales

​

$

—

​

$

7,610

​

$

877

​

$

404

​

$

21

​

$

176

​

$

105

​

$

—

​

$

9,193

Other revenues from operations

 

​

—

 

​

—

 

​

628

 

​

—

 

​

75

 

​

—

 

​

4

 

​

—

 

​

707

Net loss from investment activities

 

​

(421)

 

​

—

 

​

—

 

​

—

 

​

—

 

​

—

 

​

—

 

​

—

 

​

(421)

Interest and dividend income

 

​

335

 

​

37

 

​

4

 

​

—

 

​

1

 

​

—

 

​

2

 

​

98

 

​

477

(Loss) gain on disposition of assets, net

 

​

—

 

​

—

 

​

(7)

 

​

—

 

​

—

 

​

—

 

​

—

 

​

3

 

​

(4)

Other income (loss), net

 

​

—

 

​

37

 

​

38

 

​

(11)

 

​

—

 

​

(4)

 

​

—

 

​

8

 

​

68

​

 

​

(86)

 

​

7,684

 

​

1,540

 

​

393

 

​

97

 

​

172

 

​

111

 

​

109

 

​

10,020

Expenses:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Cost of goods sold

 

​

—

 

​

7,450

 

​

628

 

​

336

 

​

15

 

​

135

 

​

55

 

​

—

 

​

8,619

Other expenses from operations

 

​

—

 

​

—

 

​

536

 

​

—

 

​

67

 

​

—

 

​

—

 

​

—

 

​

603

Selling, general and administrative

 

​

22

 

​

166

 

​

405

 

​

50

 

​

19

 

​

43

 

​

47

 

​

31

 

​

783

Dividend expense

​

​

56

 

​

—

 

​

—

 

​

—

 

​

—

 

​

—

 

​

—

 

​

—

​

​

56

Restructuring, net

 

​

—

 

​

—

 

​

—

 

​

2

 

​

—

 

​

1

 

​

—

 

​

—

 

​

3

Interest expense

 

​

78

 

​

114

 

​

2

 

​

11

 

​

—

 

​

1

 

​

—

 

​

317

 

​

523

​

 

​

156

 

​

7,730

 

​

1,571

 

​

399

 

​

101

 

​

180

 

​

102

 

​

348

 

​

10,587

(Loss) income before income tax (expense) benefit

 

​

(242)

 

​

(46)

 

​

(31)

 

​

(6)

 

​

(4)

 

​

(8)

 

​

9

 

​

(239)

 

​

(567)

Income tax (expense) benefit

 

​

—

 

​

42

 

​

15

 

​

—

 

​

—

 

​

—

 

​

—

 

​

(32)

 

​

25

Net (loss) income

 

​

(242)

 

​

(4)

 

​

(16)

 

​

(6)

 

​

(4)

 

​

(8)

 

​

9

 

​

(271)

 

​

(542)

Less: net (loss) income attributable to non-controlling interests

 

​

(110)

 

​

14

 

​

—

 

​

(1)

 

​

—

 

​

—

 

​

—

 

​

—

 

​

(97)

Net (loss) income attributable to Icahn Enterprises

​

$

(132)

​

$

(18)

​

$

(16)

​

$

(5)

​

$

(4)

​

$

(8)

​

$

9

​

$

(271)

​

$

(445)

Supplemental information:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Capital expenditures

​

$

—

​

$

179

​

$

55

​

$

15

​

$

26

​

$

5

​

$

—

​

$

—

​

$

280

Depreciation and amortization

​

$

—

​

$

363

​

$

74

​

$

24

​

$

15

​

$

6

​

$

28

​

$

1

​

$

511

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Year Ended December 31, 2023

​

  ​ ​ ​

Investment

  ​ ​ ​

Energy

  ​ ​ ​

Automotive

  ​ ​ ​

Food Packaging

  ​ ​ ​

Real Estate

  ​ ​ ​

Home Fashion

  ​ ​ ​

Pharma

  ​ ​ ​

Holding Company

  ​ ​ ​

Consolidated

​

​

(in millions)

Revenues:

  ​ ​ ​

  ​

​

​

  ​

​

​

  ​

​

​

  ​

​

​

  ​

​

​

  ​

​

​

  ​

​

​

  ​

​

 

  ​

​

Net sales

​

$

—

​

$

9,247

​

$

1,047

​

$

446

​

$

69

​

$

175

​

$

93

​

$

—

​

$

11,077

Other revenues from operations

​

 

—

 

​

—

 

​

694

 

​

—

 

​

73

 

​

—

 

​

3

 

​

—

 

​

770

Net (loss) gain from investment activities

​

 

(1,575)

 

​

—

 

​

—

 

​

—

 

​

—

 

​

—

 

​

—

 

​

—

 

​

(1,575)

Interest and dividend income

​

 

497

 

​

38

 

​

3

 

​

—

 

​

—

 

​

—

 

​

1

 

​

97

 

​

636

(Loss) gain on disposition of assets, net

​

 

—

 

​

(2)

 

​

10

 

​

—

 

​

—

 

​

—

 

​

—

 

​

—

 

​

8

Other (loss) income, net

​

 

—

 

​

14

 

​

—

 

​

(11)

 

​

1

 

​

—

 

​

1

 

​

13

 

​

18

​

​

 

(1,078)

 

​

9,297

 

​

1,754

 

​

435

 

​

143

 

​

175

 

​

98

 

​

110

 

​

10,934

Expenses:

​

 

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Cost of goods sold

​

 

—

 

​

8,019

 

​

714

 

​

352

 

​

48

 

​

138

 

​

56

 

​

—

 

​

9,327

Other expenses from operations

​

 

—

 

​

—

 

​

581

 

​

—

 

​

62

 

​

—

 

​

—

 

​

—

 

​

643

Selling, general and administrative

​

 

26

 

​

168

 

​

465

 

​

54

 

​

17

 

​

41

 

​

45

 

​

36

 

​

852

Dividend expense

​

​

87

​

​

—

​

​

—

​

​

—

​

​

—

​

​

—

​

​

—

​

​

—

 

​

87

Restructuring, net

​

 

—

 

​

—

 

​

—

 

​

—

 

​

—

 

​

1

 

​

—

 

​

—

 

​

1

Impairment

​

 

—

​

​

—

​

​

7

​

​

—

​

​

—

​

​

—

​

​

—

​

​

—

​

​

7

Credit loss on notes receivable

​

​

—

​

​

—

​

​

—

​

​

—

​

​

—

​

​

—

​

​

—

​

​

139

​

​

139

Loss on deconsolidation

​

​

—

​

​

—

​

​

—

​

​

—

​

​

—

​

​

—

​

​

—

​

​

246

​

​

246

Interest expense

​

 

162

 

​

90

 

​

3

 

​

12

 

​

—

 

​

1

 

​

—

 

​

286

 

​

554

​

​

 

275

 

​

8,277

 

​

1,770

 

​

418

 

​

127

 

​

181

 

​

101

 

​

707

 

​

11,856

(Loss) income before income tax benefit (expense)

​

 

(1,353)

 

​

1,020

 

​

(16)

 

​

17

 

​

16

 

​

(6)

 

​

(3)

 

​

(597)

 

​

(922)

Income tax (expense) benefit

​

 

—

 

​

(189)

 

​

10

 

​

(4)

 

​

—

 

​

—

 

​

—

 

​

93

 

​

(90)

Net (loss) income

​

 

(1,353)

 

​

831

 

​

(6)

 

​

13

 

​

16

 

​

(6)

 

​

(3)

 

​

(504)

 

​

(1,012)

Less: net (loss) income attributable to non-controlling interests

​

 

(652)

 

​

323

 

​

—

 

​

1

 

​

—

 

​

—

 

​

—

 

​

—

 

​

(328)

Net (loss) income attributable to Icahn Enterprises

​

$

(701)

​

$

508

​

$

(6)

​

$

12

​

$

16

​

$

(6)

​

$

(3)

​

$

(504)

​

$

(684)

Supplemental information:

​

 

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Capital expenditures

​

$

—

​

$

205

​

$

79

​

$

14

​

$

3

​

$

2

​

$

—

​

$

—

​

$

303

Depreciation and amortization

​

$

—

​

$

363

​

$

81

​

$

25

​

$

13

​

$

7

​

$

28

​

$

1

​

$

518

​

​

Disaggregation of Revenue

In addition to the condensed statements of operations by reporting segment above, we provide additional disaggregated revenue information for our Energy and Automotive segments below.

Energy

​

​

​

​

​

​

​

​

​

​

​

​

​

Year Ended December 31, 

​

  ​ ​ ​

2025

  ​ ​ ​

2024

  ​ ​ ​

2023

​

​

(in millions)

Petroleum products

​

$

6,416

​

$

6,909

​

$

8,267

Renewable products

​

 

141

​

 

177

​

 

299

Nitrogen fertilizer products

​

 

605

​

 

524

​

 

681

​

​

$

7,162

​

$

7,610

​

$

9,247

​

Automotive

​

​

​

​

​

​

​

​

​

​

​

​

​

Year Ended December 31, 

​

  ​ ​ ​

2025

  ​ ​ ​

2024

  ​ ​ ​

2023

​

​

(in millions)

Automotive Services

​

$

1,399

​

$

1,420

​

$

1,548

Aftermarket Parts sales

​

 

2

​

 

25

​

 

137

Total revenue from customers

​

​

1,401

​

​

1,445

​

​

1,685

Lease revenue outside scope ASC 606

​

​

35

​

​

60

​

​

56

Total Automotive net sales and other revenues from operations

​

$

1,436

​

$

1,505

​

$

1,741

​

Condensed Balance Sheets

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

December 31, 2025

​

​

Investment

​

Energy

​

Automotive

​

Food
Packaging

​

Real
Estate

​

Home
Fashion

  ​ ​ ​

Pharma

​

Holding
Company

​

Consolidated

​

​

(in millions)

ASSETS

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Cash and cash equivalents

​

$

16

​

$

511

​

$

14

​

$

9

​

$

31

​

$

4

​

$

26

​

$

839

​

$

1,450

Cash held at consolidated affiliated partnerships and restricted cash

​

 

1,788

​

 

—

​

 

8

​

 

—

​

 

—

​

 

3

​

 

—

​

 

170

​

 

1,969

Investments

​

 

2,146

​

 

17

​

 

—

​

 

—

​

 

88

​

 

—

​

 

—

​

 

—

​

 

2,251

Accounts receivable, net

​

 

—

​

 

235

​

 

25

​

 

60

​

 

10

​

 

27

​

 

36

​

 

—

​

 

393

Related party note receivable

​

​

—

​

​

—

​

​

—

​

​

—

​

​

129

​

​

—

​

​

—

​

​

—

​

​

129

Inventories

​

 

—

​

 

472

​

 

165

​

 

97

​

 

—

​

 

87

​

 

24

​

 

—

​

 

845

Property, plant and equipment, net

​

 

—

​

 

2,333

​

 

351

​

 

141

​

 

787

​

 

55

​

 

—

​

 

3

​

 

3,670

Goodwill and intangible assets, net

​

 

—

​

 

139

​

 

316

​

 

21

​

 

—

​

 

21

​

 

142

​

 

—

​

 

639

Other assets

​

 

1,661

​

 

422

​

 

369

​

 

79

​

 

79

​

 

15

​

 

8

​

 

236

​

 

2,869

Total assets

​

$

5,611

​

$

4,129

​

$

1,248

​

$

407

​

$

1,124

​

$

212

​

$

236

​

$

1,248

​

$

14,215

LIABILITIES AND EQUITY

​

 

  ​

​

 

  ​

​

 

  ​

​

 

  ​

​

 

  ​

​

 

  ​

​

 

  ​

​

 

  ​

​

 

​

Accounts payable, accrued expenses and other liabilities

​

$

606

​

$

1,079

​

$

772

​

$

117

​

$

32

​

$

34

​

$

67

​

$

84

​

$

2,791

Securities sold, not yet purchased, at fair value

​

 

1,382

​

 

—

​

 

—

​

 

—

​

 

—

​

 

—

​

 

—

​

 

—

​

 

1,382

Debt

​

 

—

​

 

1,765

​

 

21

​

 

142

​

 

1

​

 

23

​

 

—

​

 

4,664

​

 

6,616

Total liabilities

​

 

1,988

​

 

2,844

​

 

793

​

 

259

​

 

33

​

 

57

​

 

67

​

 

4,748

​

 

10,789

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Equity attributable to Icahn Enterprises

​

 

2,711

​

 

722

​

 

455

​

 

139

​

 

1,091

​

 

155

​

 

169

​

 

(3,500)

​

 

1,942

Equity attributable to non-controlling interests

​

 

912

​

 

563

​

 

—

​

 

9

​

 

—

​

 

—

​

 

—

​

 

—

​

 

1,484

Total equity

​

 

3,623

​

 

1,285

​

 

455

​

 

148

​

 

1,091

​

 

155

​

 

169

​

 

(3,500)

​

 

3,426

Total liabilities and equity

​

$

5,611

​

$

4,129

​

$

1,248

​

$

407

​

$

1,124

​

$

212

​

$

236

​

$

1,248

​

$

14,215

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

December 31, 2024

​

​

Investment

​

Energy

​

Automotive

​

Food
Packaging

​

Real
Estate

​

Home
Fashion

  ​ ​ ​

Pharma

​

Holding
Company

​

Consolidated

​

​

(in millions)

ASSETS

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Cash and cash equivalents

​

$

9

​

$

987

​

$

133

​

$

6

​

$

25

​

$

4

​

$

42

​

$

1,397

​

$

2,603

Cash held at consolidated affiliated partnerships and restricted cash

​

 

2,449

​

 

—

​

 

8

​

 

—

​

 

2

​

 

4

​

 

—

​

 

173

​

 

2,636

Investments

​

 

2,272

​

 

24

​

 

—

​

 

—

​

 

14

​

 

—

​

 

—

​

 

—

​

 

2,310

Accounts receivable, net

​

 

—

​

 

295

​

 

30

​

 

75

​

 

14

​

 

28

​

 

37

​

 

—

​

 

479

Related party note receivable

​

​

—

​

​

—

​

​

—

​

​

—

​

​

—

​

​

—

​

​

—

​

​

7

​

​

7

Inventories

​

 

—

​

 

502

​

 

168

​

 

109

​

 

—

​

 

93

​

 

25

​

 

—

​

 

897

Property, plant and equipment, net

​

 

—

​

 

2,504

​

 

808

​

 

124

​

 

350

​

 

53

​

 

—

​

 

4

​

 

3,843

Goodwill and intangible assets, net

​

 

—

​

 

159

​

 

328

​

 

21

​

 

—

​

 

19

​

 

170

​

 

—

​

 

697

Other assets

​

 

1,660

​

 

280

​

 

464

​

 

90

​

 

90

​

 

19

​

 

7

​

 

197

​

 

2,807

Total assets

​

$

6,390

​

$

4,751

​

$

1,939

​

$

425

​

$

495

​

$

220

​

$

281

​

$

1,778

​

$

16,279

LIABILITIES AND EQUITY

​

 

  ​

​

 

  ​

​

 

  ​

​

 

  ​

​

 

  ​

​

 

  ​

​

 

  ​

​

 

  ​

​

 

​

Accounts payable, accrued expenses and other liabilities

​

$

817

​

$

1,509

​

$

809

​

$

107

​

$

42

​

$

43

​

$

72

​

$

77

​

$

3,476

Securities sold, not yet purchased, at fair value

​

 

1,373

​

 

—

​

 

—

​

 

—

​

 

—

​

 

—

​

 

—

​

 

—

​

 

1,373

Debt

​

 

—

​

 

1,919

​

 

31

​

 

144

​

 

1

​

 

15

​

 

—

​

 

4,699

​

 

6,809

Total liabilities

​

 

2,190

​

 

3,428

​

 

840

​

 

251

​

 

43

​

 

58

​

 

72

​

 

4,776

​

 

11,658

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Equity attributable to Icahn Enterprises

​

 

2,703

​

 

685

​

 

1,099

​

 

159

​

 

447

​

 

162

​

 

209

​

 

(2,998)

​

 

2,466

Equity attributable to non-controlling interests

​

 

1,497

​

 

638

​

 

—

​

 

15

​

 

5

​

 

—

​

 

—

​

 

—

​

 

2,155

Total equity

​

 

4,200

​

 

1,323

​

 

1,099

​

 

174

​

 

452

​

 

162

​

 

209

​

 

(2,998)

​

 

4,621

Total liabilities and equity

​

$

6,390

​

$

4,751

​

$

1,939

​

$

425

​

$

495

​

$

220

​

$

281

​

$

1,778

​

$

16,279

​

​

Geographic Information

The following table presents our consolidated geographic net sales from external customers, other revenues from operations and property, plant and equipment, net for the periods indicated:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Property, Plant and

​

​

Net Sales

​

Other Revenues From Operations

​

Equipment, Net

​

​

Year Ended December 31, 

​

Year Ended December 31, 

​

December 31, 

​

  ​ ​ ​

2025

  ​ ​ ​

2024

  ​ ​ ​

2023

  ​ ​ ​

2025

  ​ ​ ​

2024

  ​ ​ ​

2023

  ​ ​ ​

2025

  ​ ​ ​

2024

​

(in millions)

United States

​

$

8,287

​

$

8,837

​

$

10,687

​

$

633

​

$

677

​

$

742

​

$

3,556

​

$

3,731

International

​

 

344

​

 

356

​

 

390

​

 

31

​

 

30

​

 

28

​

 

114

​

 

112

​

​

$

8,631

​

$

9,193

​

$

11,077

​

$

664

​

$

707

​

$

770

​

$

3,670

​

$

3,843

​

Geographic locations for net sales and other revenues from operations are based on locations of the customers and geographic locations for property, plant, and equipment are based on the locations of the assets.